Profile data is unavailable for this security.
About the company
Vitrolife AB is a Sweden-based company engaged in assisted reproduction services. The Company’s product portfolio comprises G-RINSE, which is a solution for rinsing of contact materials, EmbryoGlue, which is a human albumin recombinant, ASP, which is a solution for oocyte retrieval and rinsing, and Semen VTS, which is a viscosity treatment system, among others. It also provides a range of procedural solutions for sperm preparation, vitrification, embryo transfer and oocyte retrieval, such as temperature control, condition control, gamete-safe labware and embryo support. The Company is active in Australia, China, France, Italy, Japan, the United States and the United Kingdom, among others, and conducts its business through a number of subsidiaries, such as Vitrolife Ltd., Vitrolife Pty Ltd., and A.T.S. Srl.
- Revenue in SEK (TTM)3.50bn
- Net income in SEK-3.84bn
- Incorporated1989
- Employees1.13k
- LocationVitrolife ABGustaf Werners gata 2, Vastra FrolundaGOETEBORG 421 32SwedenSWE
- Phone+46 317218000
- Fax+46 317218099
- Websitehttps://www.vitrolife.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
CellaVision AB | 708.28m | 141.22m | 5.94bn | 223.00 | 42.06 | 7.83 | 32.65 | 8.39 | 5.92 | 5.92 | 29.69 | 31.81 | 0.757 | 1.68 | 8.45 | 3,106,469.00 | 15.09 | 15.30 | 17.34 | 18.24 | 67.52 | 69.03 | 19.94 | 19.98 | 2.21 | 66.29 | 0.0688 | 110.18 | 5.94 | 13.17 | 10.12 | 8.00 | 30.45 | 8.45 |
Surgical Science Sweden AB | 842.02m | 207.95m | 6.17bn | 265.00 | 29.68 | 1.35 | 23.31 | 7.33 | 4.08 | 4.08 | 16.51 | 89.92 | 0.1749 | 1.68 | 6.12 | 3,238,531.00 | 4.32 | 4.49 | 4.59 | 4.78 | 68.59 | 70.06 | 24.70 | 23.75 | 3.53 | -- | 0.00 | 0.00 | 10.01 | 68.14 | 24.47 | -- | 38.57 | -- |
Revenio Group Oyj | 1.10bn | 216.10m | 8.27bn | 216.00 | 37.86 | 7.26 | 31.71 | 7.53 | 0.7205 | 0.7205 | 3.66 | 3.76 | 0.7069 | 5.50 | 7.60 | 447,574.10 | 13.90 | 14.33 | 16.77 | 17.90 | 51.01 | 50.73 | 19.66 | 21.13 | 1.79 | 28.49 | 0.1521 | 55.81 | -0.4125 | 25.80 | -12.15 | 18.72 | 17.67 | 6.30 |
ChemoMetec A/S | 612.00m | 219.17m | 9.20bn | 171.00 | 41.98 | 12.10 | 37.21 | 15.03 | 8.26 | 8.26 | 23.07 | 28.66 | 0.6982 | 0.8064 | 6.01 | 2,448,421.00 | 25.00 | 30.43 | 29.69 | 38.99 | 78.85 | 79.44 | 35.81 | 34.17 | 3.37 | -- | 0.0118 | 46.90 | 3.74 | 31.58 | 12.04 | 57.88 | 19.91 | -- |
Arjo AB (publ) | 11.10bn | 518.00m | 10.35bn | 6.71k | 21.41 | 1.37 | 6.68 | 0.9323 | 1.90 | 1.90 | 40.76 | 29.72 | 0.6911 | 4.15 | 6.31 | 1,632,980.00 | 3.21 | 3.55 | 4.44 | 5.55 | 43.43 | 44.01 | 4.64 | 5.41 | 0.6913 | 4.14 | 0.4024 | 43.01 | 10.03 | 5.97 | 6.90 | 10.15 | -8.89 | 10.35 |
Biotage AB | 1.98bn | 236.00m | 12.81bn | 669.00 | 53.18 | 3.29 | 31.78 | 6.47 | 3.01 | 3.01 | 25.57 | 48.61 | 0.5276 | 2.01 | 7.78 | 2,939,169.00 | 6.29 | 10.74 | 7.33 | 12.77 | 62.19 | 61.34 | 11.91 | 15.77 | 1.52 | 8.95 | 0.062 | 40.11 | 18.90 | 15.37 | -8.21 | 7.97 | 14.05 | 1.30 |
Xvivo Perfusion AB | 642.95m | 100.43m | 12.85bn | 148.00 | 123.00 | 6.42 | 77.96 | 19.99 | 3.32 | 3.32 | 21.18 | 63.59 | 0.322 | 1.28 | 4.27 | 4,018,431.00 | 5.03 | 1.24 | 5.49 | 1.33 | 73.94 | 73.14 | 15.62 | 4.76 | 3.40 | -- | 0.0152 | 0.00 | 43.88 | 26.04 | 398.29 | 48.57 | 21.35 | -- |
Embla Medical hf | 8.51bn | 602.26m | 19.22bn | 4.00k | 31.83 | 2.48 | 16.80 | 2.26 | 0.9263 | 0.9263 | 13.07 | 11.88 | 0.5582 | 2.20 | 6.60 | 1,396,049.00 | 3.96 | 4.06 | 4.68 | 4.76 | 61.41 | 62.47 | 7.09 | 6.91 | 1.07 | 5.81 | 0.4325 | 3.99 | 9.33 | 5.09 | 37.34 | -6.05 | 6.50 | -- |
Vitrolife AB | 3.50bn | -3.84bn | 22.63bn | 1.13k | -- | 1.71 | -- | 6.47 | -28.33 | -28.33 | 25.84 | 97.73 | 0.1859 | 3.76 | 6.54 | 3,242,818.00 | -20.38 | -4.57 | -21.03 | -4.78 | 56.39 | 58.38 | -109.60 | -21.89 | 2.98 | -30.31 | 0.1353 | -- | 8.60 | 24.99 | -1,077.41 | -- | -7.95 | 3.30 |
Elekta AB (publ) | 18.12bn | 1.30bn | 24.14bn | 4.58k | 19.29 | 2.32 | 9.89 | 1.33 | 3.40 | 3.40 | 47.32 | 28.20 | 0.5939 | 3.58 | 3.01 | -- | 4.27 | 4.19 | 7.60 | 7.51 | 37.55 | 39.03 | 7.19 | 7.37 | 0.7644 | 3.85 | 0.4021 | 71.71 | 7.41 | 5.98 | 38.07 | 1.68 | 20.06 | 5.92 |
Sectra AB | 1.73bn | 428.39m | 43.48bn | 1.14k | 108.03 | 29.48 | 81.65 | 25.20 | 2.22 | 2.22 | 8.95 | 8.15 | 0.5801 | -- | 3.60 | 1,513,253.00 | 14.41 | 15.75 | 28.61 | 29.52 | 47.24 | 64.95 | 24.83 | 19.59 | -- | -- | 0.0199 | -- | 26.84 | 4.06 | 14.25 | 16.58 | 48.37 | -- |
Getinge AB | 32.20bn | 2.28bn | 45.93bn | 11.86k | 21.55 | 1.52 | 10.94 | 1.43 | 8.39 | 8.39 | 118.22 | 118.80 | 0.6001 | 2.53 | 6.79 | 2,742,908.00 | 4.29 | 5.31 | 5.56 | 6.98 | 45.37 | 47.83 | 7.15 | 8.69 | 0.7569 | 8.93 | 0.2035 | 37.87 | 12.49 | 5.66 | -3.17 | -- | -0.3944 | 34.49 |
Ambu A/S | 7.73bn | 559.35m | 48.87bn | 4.75k | 98.78 | 6.48 | 43.62 | 6.32 | 1.38 | 1.38 | 19.09 | 21.05 | 0.7251 | 2.13 | 7.17 | 1,099,437.00 | 5.24 | 3.81 | 5.99 | 4.62 | 57.91 | 59.37 | 7.23 | 5.43 | 1.49 | 16.93 | 0.101 | 22.89 | 7.45 | 12.88 | 80.65 | -13.00 | 6.67 | -- |
Holder | Shares | % Held |
---|---|---|
AMF Fonder ABas of 04 Jan 2024 | 6.90m | 5.09% |
Swedbank Robur Fonder ABas of 31 May 2024 | 5.03m | 3.72% |
Fj�rde AP-fondenas of 31 Dec 2023 | 4.76m | 3.52% |
Handelsbanken Fonder ABas of 31 May 2024 | 3.12m | 2.30% |
SEB Investment Management ABas of 31 May 2024 | 2.73m | 2.02% |
The Vanguard Group, Inc.as of 06 Jun 2024 | 2.36m | 1.74% |
Cliens Kapitalf�rvaltning ABas of 31 Dec 2023 | 2.28m | 1.68% |
Tredje AP-fondenas of 31 Aug 2023 | 1.74m | 1.29% |
Norges Bank Investment Managementas of 31 Aug 2023 | 1.53m | 1.13% |
C Worldwide Asset Management Fondsm�glerselskab A/S (Sweden)as of 31 Dec 2023 | 1.33m | 0.99% |